Patient-centered, physician-partner, employee-based
Hubei Provincial People's HospitPerforms FCVB Surgery Again, Offering "Eye-Preserving" Hope to Patients with Severe Ocular Trauma
Release time: Oct 28,2025
"If it had been a little later, this eye would have been really lost." In the ophthalmology consulting room of Hubei Provincial People's Hospital, Mr. L, who had just completed the preoperative evaluation, still felt lingering fear when recalling the accident a month ago. A month ago, he accidentally scratched his right eye with an iron sheet at work, causing massive bleeding and a sudden sharp drop in vision. He urgently underwent multiple emergency surgeries such as right corneal laceration suture. However, no further treatment was performed after the operation, leading to increasingly severe eye atrophy. With an urgent desire to "preserve his eyeball," he came to the ophthalmology department of Hubei Provincial People's Hospital for further treatment. The foldable capsular vitreous body (FCVB) technology has brought a turning point for his right eye on the verge of atrophy.
After receiving Mr. L, Professor Jin Wei's team from the ophthalmology department of Hubei Provincial People's Hospital found through detailed ophthalmic examinations that Mr. L's right eye had shown obvious signs of atrophy due to severe trauma and missing the best treatment time. "Traditional silicone oil tamponade treatment has limited effect in such cases of severe atrophy. It is not only difficult to effectively support the eyeball structure, but may also cause subsequent problems such as glaucoma and corneal degeneration. If a silicone oil-dependent eye is formed, repeated surgeries are required, which cannot meet the patient's core demand of preserving the eyeball," Professor Jin explained.
In the field of ocular trauma treatment, "preserving the eyeball" has always been an important goal pursued by both doctors and patients. Eyeball atrophy not only leads to permanent loss of vision, but also causes changes in the appearance of the eye, bringing enormous psychological pressure to patients. In traditional treatment methods, for patients at high risk of eyeball atrophy after severe ocular trauma, they often have to choose enucleation combined with orbital implant implantation. Although this method can improve the appearance, it makes the patient lose their own eyeball forever, and requires multiple prosthetic eye repairs after the operation, with a long treatment cycle and poor experience.
How to achieve a breakthrough in "preserving the eyeball" for patients with severe ocular trauma?
The emergence of the foldable capsular vitreous body (FCVB) has provided an innovative solution to this problem.
Foldable Capsular Vitreous Body (FCVB)
FCVB is the world's first innovative international product that mimics the human natural vitreous body. It consists of a capsular body, a drainage tube, a drainage valve, and a fixation loop. The capsular body is precisely designed based on computer-simulated parameters of the human vitreous cavity, featuring a special planar crystalline surface design. It is made of medical silicone polymer imported with the approval of the U.S. Food and Drug Administration (FDA). During surgery, the capsular body is folded and implanted into the vitreous cavity, then filled with silicone oil through the drainage valve. The capsular body is secured intraocularly by double-loop sutures of the fixation loop and drainage tube, which isolates the ciliary body from damage caused by silicone oil.
The capsular body can preserve the posterior chamber space, allowing the ciliary body to gradually recover its function, rescue the dysfunctional ciliary body, and maintain intraocular pressure. It also prevents silicone oil emulsification and migration, provides all-round support for the retina, and maintains the normal shape of the eyeball.
"Preserving the eyeball is not just about retaining an organ, but also about preserving the patient's quality of life and psychological dignity," Professor Jin said. The hospital has always been committed to introducing international cutting-edge ocular trauma treatment technologies into clinical practice. The mature development of foldable capsular vitreous body (FCVB) surgery is a reflection of the hospital's technical strength in the field of eye-preserving treatment for severe ocular trauma. This technology has been successfully applied to more than 6,000 eye disease patients worldwide, helping them get rid of the predicament of enucleation and regain confidence in life.
Here, we also remind friends: after an ocular trauma occurs, the golden emergency time is crucial. It is imperative to go to the ophthalmology department of a regular hospital for treatment as soon as possible to avoid serious consequences such as eyeball atrophy due to delayed treatment. For patients with ocular trauma who have received initial treatment, regular re-examinations and timely detection and treatment of postoperative complications are the key to preventing eyeball atrophy and preserving visual function. When traditional treatment methods are difficult to meet the demand of preserving the eyeball, the foldable capsular vitreous body (FCVB) technology can bring new hope to patients.
During the postoperative review, Xiao Z’s left-eye retinal break was completely closed, the symptoms of photopsia and floaters disappeared, and his corrected visual acuity improved. "We didn't expect such a quick recovery. The child only missed a few classes and returned to campus soon. We are truly grateful to the medical team!" the parents said, expressing their deep thanks to the president and Professor Zhou.
11/06
Postoperative examinations showed that the retinal break of the right eye was well-apposed on the scleral ridge, with other examination results remaining basically unchanged. The patient and her family expressed great satisfaction with the surgical outcome and extended their gratitude to the medical team.
11/05
R&D Center
Media
Cases
Search for product information you are interested in
CONTACT US
+8618960050093
Building11,No.6,Nanjiang 2nd Road, Zhujiang Street, Nansha District,Guangzhou
©COPYRIGHT 2024 Guangzhou Vesber Biotechnology Co., Ltd. | SEO Tags Privacy Policy
License